Associations of prenatal and childhood antibiotic use with child body mass index at age 3 years

Obesity

Volumn 25, Issue 2, 2017, Pages 438-444

  Poulsen, Melissa N ^a,b   Pollak, Jonathan ^a   Bailey Davis, Lisa ^b   Hirsch, Annemarie G ^b   Glass, Thomas A ^c   Schwartz, Brian S ^a,b,c  

^a Johns Hopkins University   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; MACROLIDE; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; BODY MASS INDEX Z SCORE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; PENNSYLVANIA; PREGNANCY; PRENATAL AND CHILDHOOD ANTIBIOTIC USE; PRENATAL CARE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TREND STUDY; WEIGHT REDUCTION; BODY WEIGHT; DRUG EFFECTS; PATHOPHYSIOLOGY; PRENATAL EXPOSURE; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BODY MASS INDEX; BODY WEIGHT; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PENNSYLVANIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TIME FACTORS;

EID: 85010280320     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21719     Document Type: Article

References (32)

1. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol 2015;11:182-190.
2. Perrini F. Aureomycin as growth factor in prematures. Boll Soc Ital Biol Sper 1951;27:1151-1152.
3. Robinson P. Controlled trial of aureomycin in premature twins and triplets. Lancet 1952;259:52.
4. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031.
5. Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011;94:58-65.
6. Angelakis E, Merhej V, Raoult D. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 2013;13:889-899.
7. Sanmiguel C, Gupta A, Mayer EA. Gut microbiome and obesity: a plausible explanation for obesity. Curr Obes Rep 2015;4:250-261.
8. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med 2015;21:109-117.
9. Mikkelsen KH, Allin KH, Knop FK. Effect of antibiotics on gut microbiota, glucose metabolism and bodyweight regulation - a review of the literature. Diabetes Obes Metab 2016;18:444-453.
10. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010;156:3216-3223.
11. Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 2016;7:10410.
12. Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014;158:705-721.
13. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011;35:522-529.
14. Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 2014;38:1290-1298.
15. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 2014;168:1063-1069.
16. Murphy R, Stewart AW, Braithwaite I, et al. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int J Obes (Lond) 2014;38:1115-1119.
17. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 2015;135:617-626.
18. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013;37:16-23.
19. Gerber JS, Bryan M, Ross RK, et al. Antibiotic exposure during the first 6 months of life and weight gain during childhood. JAMA 2016;315:1258-1265.
20. Scott FI, Horton DB, Mamtani R, et al. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology 2016;151:120-129.
21. Schwartz BS, Pollak J, Bailey-Davis L, et al. Antibiotic use and childhood body mass index trajectory. Int J Obes (Lond) 2015;40:615-621.
22. Mor A, Antonsen S, Kahlert J, et al. Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study. Int J Obes (Lond) 2015;39:1450-1455.
23. Mueller NT, Whyatt R, Hoepner L, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 2015;39:665-670.
24. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 2013;21:167-173.
25. Casey JA, Savitz DA, Rasmussen SG, et al. Unconventional natural gas development and birth outcomes in Pennsylvania, USA. Epidemiology 2016;27:163-172.
26. Martin JA, Hamilton BE, Osterman MJK, Curtin SC, Matthews TJ. Births: Final Data for 2013. Division of Vital Statistics, Centers for Disease Control and Prevention; 2015.
27. Foote JM, Brady LH, Burke AL, et al. Development of an evidence-based clinical practice guideline on linear growth measurement of children. J Pediatr Nurs 2011;26:312-324.
28. Medi-Span. Master Drug Data Base Documentation Manual. Indianapolis, IN: Medi-Span; 2007.
29. Schwartz BS, Bailey-Davis L, Bandeen-Roche K, et al. Attention deficit disorder, stimulant use, and childhood body mass index trajectory. Pediatrics 2014;133:668-676.
30. Bandeen-Roche K, Hall CB, Stewart WF, Zeger SL. Modelling disease progression in terms of exposure history. Stat Med 1999;18:2899-2916.
31. Kuhle S, Tong OS, Woolcott CG. Association between caesarean section and childhood obesity: a systematic review and meta-analysis. Obes Rev 2015;16:295-303.
32. Woo Baidal J, Locks L, Cheng E, Blake-Lamb T, Perkins M, Taveras E. Risk factors for childhood obesity in the first 1,000 days: a systematic review. Am J Prev Med 2016;50:761-779.